Intrinsic value of Adaptimmune Therapeutics plc (ADAP)
Live fair value data for Adaptimmune Therapeutics plc (ADAP) is currently unavailable. Please check again shortly.
Current Price: $78.00
Valuation: Undervalued
Confidence: 4.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Adaptimmune Therapeutics plc (ADAP) undervalued or overvalued?
Based on the current model output, Adaptimmune Therapeutics plc appears to be undervalued with a upside of 1.00%.
Fair value vs market price — Adaptimmune Therapeutics plc (ADAP)
Unlock premium access to view the live fair value comparison against current market price for ADAP.
Frequently Asked Questions - ADAP
How is ADAP intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for ADAP.
Is ADAP undervalued or overvalued right now?
ADAP is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for ADAP: open their intrinsic value pages.